Work

Safety and efficacy of eniluracil + capecitabine (6422 + Cap) in phase 1b trial.

Year: 2025

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e15152

Authors: David Young, Sian Elizabeth Bigora, Mary Nyberg, Maya Das, Amit Mahipal, Patrick M. Boland, Eric Jay Feldman, Howard S. Hochster

Institutions: Processa Pharmaceuticals, Inc. (United States), University Hospitals Cleveland Medical Center, Rutgers Cancer Institute, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410816704

FWCI:

Cites:

Cited by:

Related to: 10